Cracking the MS Code
  • HOME
  • Blog
  • About
  • Our Project
  • GET INVOLVED

bacterial diagnostic data—akkermansia or bust!

5/16/2019

0 Comments

 
Being the determined sort, my research team attempted to grow up nine MS bacterial candidates in culture. We chose these early MS bacterial candidates from our very first sequencing run, so they are not what we would choose now. And growing these in pure culture wasn’t easy, since many were anaerobes which grow slowly and are fussy about media. ​​We grew Akkermansia, Parabacteroides, Atopobium,
Picture
Atopobium vaginae gram stain
Propionibacterium (now Cutibacterium) acnes, Lactobacillus, Borrelia burgdorferei, and a few others. (This work is covered by the provisional US Patent Application #62785377, filed 12/27/18.)
 
We took cerebrospinal fluid (CSF) from 14 patients with MS (and other demyelinating diseases) and compared the CSF to a set of four controls who had no active infection at the time of collection. Among these 14 patients, the CSF from seven  reacted against Akkermansia. This includes one patient whose first CSF sample did not react but a second sample, taken three weeks later, was strongly reactive. This patient developed anti-Akkermansia antibodies in his spinal fluid over the course of a few weeks, one chilling aspect of the process of this terrible disease.

Interestingly, we also collected spinal fluid from three patients who had had brain biopsies, so we had some idea about what microbes we might find. Two of these three patients had RNA sequences that mapped to Akkermansia. We detected anti-Akkermansia antibodies in their CSF, more than five years after their initial attack and brain biopsy. (Antibodies are stable and long-lasting but they are cleared in months, not years.) For the other patient, we did not detect Akkermansia in the brain tissue, and no antibodies against that bacterium appeared in the cerebrospinal fluid. 
Picture
Akkermansia muciniphila gram stain
My team believes our evidence shows Akkermansia may be the cause of ongoing MS in research subject 019. That's one patient, with one traceable link to a bacterial cause of MS.
 
Yes, the numbers are small—the number of MS patients whose CSF we examined, the number of controls, and the number of studies completed—but the findings are compelling so far, and worth exploring. My colleagues and I want to examine the oligoclonal bands (OCBs) in those two patients with Akkermansia RNA and antibodies in CSF against it. With time and funding, we hope to do exactly that kind of encompassing research. You won’t be surprised to hear that testing for oligoclonal bands requires specialized techniques involving the absorption of antibodies in cerebrospinal fluid. Very expensive tests that are, again, so worth pursuing.
 
Could the oligoclonal bands prevalent in MS patients be directed against bacteria? Sure, no one has tested for it. We plan to. The field begs for extensive inquiry and research.
 
Still, even if the OCBs are proven to be directed against bacteria, we can’t guarantee that treating those bacteria directly will improve the disease. We might, as with neurosyphilis or neurologic Lyme disease, be able to limit the damage. But often the neurologic deficits do not reverse. 
 
In full disclosure—and if you’ve read this far, you are able to withstand the bumps and bruises that medical research delivers—bacterial infections in the brain may actually “trigger” MS, setting off the disease, then vanish like a ghost.
 
Or those bacterial infections might stay and fester, causing progressive MS.
 
Or new infections might occur, causing relapses of existing MS. 

In every one of these instances, case-specific bacterial diagnostic tools would be very helpful in our campaign to help MS patients. I will be pursuing this bacteriological line of inquiry in my research and in this blog until the real culprits of MS step forward to claim their ignominious prize: the causal actors in MS.
 
You can help by donating to our MS research, writing to the National MS Society about the importance of this research, and sharing this blog on social media. The more minds we get searching for the cause of MS, the better. Thank you for your interest!
​
Picture
Pseudomonas colonies on an agar plate
All images are from our Microbes in MS research lab.
0 Comments

    Author

    Dr. John Kriesel is Associate Professor of Infectious Diseases at the University of Utah School of Medicine. ​He began this blog to raise awareness and generate discussion about the possible causes of multiple sclerosis.

    BLOG ETIQUETTE
    All readers are welcome to post replies and challenge ideas. Please respect the process and keep the dialog civil.
    subscribe to the blog
    Get involved
    donate to microbes in mS research

    Archives

    March 2021
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019

    Categories

    All

    RSS Feed

THANKS FOR YOUR INTEREST

The opinions on this website are not necessarily those of the University of Utah. The site was assembled with private, not university funds. ​​This blog is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this blog or materials linked from this blog is at the user’s own risk. The content of this blog is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.

  • HOME
  • Blog
  • About
  • Our Project
  • GET INVOLVED